Clinical

Dataset Information

0

Fruquintinib Plus Capecitabine as Maintenance Treatment of RAS / BRAF Wild-type Metastatic Colorectal Cancer


ABSTRACT: This phase I/II study was designed to evaluate the efficacy and safety of fruquintinib combination with capecitabine in maintenance treatment after first-line chemotherapy combined with cetuximab.

DISEASE(S): Metastatic Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2387531 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR

Similar Datasets

| 2740471 | ecrin-mdr-crc
| S-EPMC7372324 | biostudies-literature
| 2698605 | ecrin-mdr-crc
| 2365787 | ecrin-mdr-crc
| S-EPMC9071922 | biostudies-literature
| S-EPMC6864846 | biostudies-literature
| S-EPMC6864846 | biostudies-literature
| S-EPMC11300202 | biostudies-literature
| 3051 | ecrin-mdr-crc
| S-EPMC5031350 | biostudies-literature